Efficacy of Genotype-matched Vaccine Against Re-emerging Genotype V Japanese Encephalitis Virus,Emerging Microbes & Infections

当前位置： X-MOL 学术 › Emerg. Microbes Infect. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Efficacy of Genotype-matched Vaccine Against Re-emerging Genotype V Japanese Encephalitis Virus
Emerging Microbes & Infections ( IF 13.2 ) Pub Date : 2024-04-15 , DOI: 10.1080/22221751.2024.2343910
Jae-Deog Kim _{1,

2} , Ah-Ra Lee _{1,

2} , Dah-Hyun Moon ₃ , Young-Uk Chung _{1,

2} , Su-Yeon Hong _{1,

2} , Hyo Je Cho ₄ , Tae Hyun Kang ₅ , Yo Han Jang ₆ , Myung Hyun Sohn ₇ , Baik-Lin Seong _{8,

9} , Sang-Uk Seo _{1,

2}

Affiliation

Department of Biomedicine & Health Sciences, Graduate School, The Catholic University of Korea, Seoul, Republic of Korea
Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
The Interdisciplinary Graduate Program in Integrative Biotechnology & Translational Medicine, Yonsei University, Incheon, Republic of Korea
Department of Biochemistry, Chungbuk National University, Cheongju, Republic of Korea
Department of Biopharmaceutical Chemistry, Kookmin University, Seoul, Republic of Korea
Department of Vaccine Biotechnology, Andong National University, Andong, Republic of Korea
Department of Pediatrics, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea
Department of Microbiology and Immunology, College of Medicine, Yonsei University, Seoul, Republic of Korea
Vaccine Innovative Technology ALliance (VITAL)-Korea, Yonsei University, Seoul, Republic of Korea

Japanese encephalitis (JE), caused by the Japanese encephalitis virus (JEV), is a highly threatening disease with no specific treatment. Fortunately, the development of vaccines has enabled effecti...

中文翻译：